Sensata Technologies Holding plc announced that Paul Vasington, Executive Vice President and Chief Financial Officer, has decided to retire from the Company, effective immediately following the filing of the Quarterly Report on Form 10-Q for the third quarter 2023 (the "Form 10-Q Filing") in early November. Mr. Vasington will remain with the Company through a transition period and will remain as an advisor to Jeff Cote, Chief Executive Officer and President, until April 2, 2024. October 31, 2023, the Company announced that Brian K. Roberts has been named as the Company's new Chief Financial Officer (?CFO?).

Mr. Roberts, age 52, has decades of finance, operational, and leadership experience across several industries, including marketing and technology services, medical device manufacturing, and life sciences. Most recently, Mr. Roberts was the Chief Executive Officer of Tarveda Therapeutics, a private venture backed oncology company, which he joined initially as Chief Financial Officer in 2018. Mr. Roberts has extensive public company operating experience including as Chief Financial Officer at both Insulet Corporation, a high-growth medical technology business and Digitas Inc., through its successful acquisition by Publicis Groupe.

Mr. Roberts also has significant public board experience including serving for eight years as Audit Committee Chair for ViewRay Inc. Mr. Roberts started his career at Ernst & Young and is a Certified Public Accountant. He holds a Bachelor of Science in Accounting and Finance from Boston College.